Technological regimes and demand structure in the evolution of the pharmaceutical industry

Journal of Evolutionary Economics

Volumn 22, Issue 4, 2012, Pages 677-709

  Garavaglia, Christian ^a,b   Malerba, Franco ^b   Orsenigo, Luigi ^b,c   Pezzoni, Michele ^a,b,d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b BOCCONI UNIVERSITY   (Italy)

^c SCUOLA UNIVERSITARIA SUPERIORE IUSS PAVIA   (Italy)

^d Observatoire des Sciences et des Techniques   (France)

Author keywords

History friendly model; Industrial dynamics; Innovation; Market structure; Pharmaceuticals

Indexed keywords

EID: 84865830348     PISSN: 09369937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00191-012-0285-1     Document Type: Article

References (36)

1. Adner R (2002)1 When are technologies disruptive: a demand-based view of the emergence of competition. Strat Manag J 23: 667-688.
2. Adner R, Levinthal D (2001) Demand heterogeneity and technology evolution: implications for product and process innovation. Manag Sci 47(5): 611-628.
3. Bottazzi G, Dosi G, Lippi M, Pammolli F, Riccaboni M (2001) Innovation and corporate growth in the evolution of the drug industry. Int J Ind Organ 19(7): 1161-1187.
4. Breschi S, Malerba F, Orsenigo L (2000) Technological regimes and schumpeterian patterns of innovation. Econ J 110: 388-410.
5. Buenstorf G, Klepper S (2010) Submarket dynamics and innovation: the case of the U. S. tire industry. Ind Corp Change 19(5): 1563-1587.
6. Chandler AD (2005) Shaping the industrial century: the remarkable story of the modern chemical and pharmaceutical industries (Harv Stud Bus Hist), Harvard University Press, Cambridge, MA.
7. Comanor WS (1986) The political economy of the pharmaceutical industry. J Econ Lit 24: 1178-1217.
8. Dalle J-M (1997) Heterogeneity vs. externalities in technological competition: a tale of possible technological landscapes. J Evol Econ 7: 395-413.
9. Di Masi J, Hansen R, Grabowski H (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22(2): 151-185.
10. Galambos L, Sturchio J (1996) The pharmaceutical industry in the twentieth century: a reappraisal of the sources of innovation. Hist Technol 13(2): 83-100.
11. Gambardella A (1995) Science and innovation in the US pharmaceutical industry. Cambridge University Press, Cambridge.
12. Garavaglia C (2010) Modelling industrial dynamics with 'history-friendly' simulations. Struct Chang Econ Dyn 21(4): 258-275.
13. Garavaglia C, Malerba F, Orsenigo L, Pezzoni M (2010) A history-friendly model of the evolution of the pharmaceutical industry: technological regimes and demand structure, KITeS Working Paper.
14. Grabowski H, Vernon J (1994) Innovation and structural change in pharmaceuticals and biotechnology. Ind Corp Change 3(2): 435-449.
15. Henderson R, Orsenigo L, Pisano GP (1999) The pharmaceutical industry and the revolution in molecular biology: exploring the interactions between scientific, institutional and organizational change. In: Mowery DC, Nelson RR (eds) The sources of industrial leadership. Cambridge University Press, Cambridge.
16. Klepper S (1996) Entry, exit, growth and innovation over the product life cycle. Am Econ Rev 86: 562-583.
17. Klepper S (1997) Industry life cycles. Ind Corp Change 6(8): 145-181.
18. Klepper S, Simons K (2000a) Dominance by birthright: entry of prior radio producers and competitive ramifications in the US television receiver industry. Strateg Manag J 21: 997-1016.
19. Klepper S, Simons K (2000b) The making of an oligopoly: firm survival and techniological change in the evolution of the U. S. tire industry. J Polit Econ 108: 728-760.
20. Klepper S, Thompson P (2006) Submarkets and the evolution of market structure. RAND J Econ 37(4): 861-886.
21. Malerba F, Nelson R, Orsenigo L, Winter S (1999) History-friendly models of industry evolution: the computer industry. Ind Corp Change 8(1): 3-40.
22. Malerba F, Nelson R, Orsenigo L, Winter S (2007) Demand, innovation, and the dynamics of market structure: the role of experimental users and diverse preferences. J Evol Econ 17: 371-399.
23. Malerba F, Nelson RR, Orsenigo L, Winter SG (2008) Vertical integration and disintegration of computer firms: a history-friendly model of the co-evolution of the computer and semiconductor industries. Ind Corp Change 17: 197-231.
24. Malerba F, Orsenigo L (2002) Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history-friendly model. Ind Corp Change 11(4): 667-703.
25. Matraves C (1999) Market structure, R&D and advertising in the pharmaceutical industry. J Ind Econ 47(2): 169-194.
26. Nelson R, Winter S (1982) An evolutionary theory of economic change. The Belknapp Press of Harvard University Press, Cambridge.
27. Pammolli F (1996) Innovazione, Concorrenza a Strategie di Sviluppo nell'Industria Farmaceutica, Guerini Scientifica.
28. Pavitt K (1984) Sectoral patterns of technical change: towards a taxonomy and a theory. Res Policy 13(6): 343-373.
29. Pisano G (1996) The development factory: unlocking the potential of process innovation. Harvard Business School Press.
30. Saviotti P (1996) Technological evolution. Variety and the economy. Edward Elgar, Cheltenham.
31. Scherer FM (2000) The pharmaceutical industry. In: Culyer AJ, Newhouse JP (eds) Handbook of health economics, I. Elsevier, Amsterdam, pp 1297-1336.
32. Schwartzman D (1976) Innovation in the pharmaceutical industry. John Hopkins University Press, Baltimore.
33. Sutton J (1998) Technology and market structure: theory and history. MIT Press, Cambridge.
34. Windrum P, Birchenhall C (1998) Is product life cycle theory a special case? Dominant designs and the emergence of market niches through coevolutionary-learning. Struct Chang Econ Dyn 9: 109-134.
35. Windrum P, Birchenhall C (2005) Structural change in presence of network externalities: a co-evolutionary model of technological successions. J Evol Econ 15: 123-148.
36. Winter S (1984) Schumpeterian competition in alternative technological regimes. J Econ Behav Organ 5(3-4): 287-320.